appeals court rejected Novo Nordisks legal challenge to the program, marking a key setback that keeps the negotiation process on track
Semaglutide (Wegovy) works by mimicking a hormone called GLP-1 (glucagon-like peptide-1) that targets areas of the brain involved in appetite regulation
[9] According to the FDA prescribing information, nausea occurred in 12-24% of patients, vomiting in 2-11%, and diarrhea in 7-17%, with rates varying by dose (5 mg, 10 mg, or 15 mg weekly)
Kojic acid (5500mg) 3
Getting this wrong means overdosing or underdosing, and the FDA has received hundreds of adverse event reports related to exactly this type of dosing error with compounded semaglutide products
Recently, there has been a lot of talk about using semaglutide with B12 injections